Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06873737

Analysis of the Levels of HLADR+ Extracellular Vesicles in Women With Preeclampsia as a Early Potential Biomarker

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Analysis of the circulating levels of placenta-derived HLA-DR+ extracellular vesicles in the first, second and third trimester of pregnancy of women with high and low risk to develop preeclampsia.

Detailed description

The aim of this study is to analyze the levels of circulating placenta-derived HLA-DR+ extracellular vesicles in the first, second and third trimester of pregnancy of women with high and low risk to develop preeclampsia to investigate the potential role of HLA-DR as early biomarker.

Conditions

Interventions

TypeNameDescription
OTHERBlood samples for inflammatory markersBlood sampling in the first, second, trimester of pregnancy

Timeline

Start date
2022-09-01
Primary completion
2023-09-30
Completion
2026-01-01
First posted
2025-03-13
Last updated
2025-03-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06873737. Inclusion in this directory is not an endorsement.